Science AI Journal

Molecular Pain

ISSN 1744-8069 · SAGE Publishing · United Kingdom · active 1989–2026

Metrics

Scimago quartile
Q1
Cites per paper (2y)
2.1
SJR
1.058
h-index
116

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.

Indexing & access

DOAJScopusWeb of SciencePubMed

Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Scope

painmechanismstreatmentsphysiologyneuropeptidesanimalcellularmolecularneuroscienceionchannelregulation

Frequently asked

Is Molecular Pain a predatory journal?

Our screening does not flag Molecular Pain. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.

Is Molecular Pain indexed in Scopus or Web of Science?

Per our venue index, Molecular Pain appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is Molecular Pain's impact?

Papers in Molecular Pain are cited about 2.1 times each within two years of publication, and Scimago places it in Q1, with an h-index of 116. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.

Is Molecular Pain open access?

Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.

Similar venues

Command palette

Jump anywhere, run any action.